Eisler Capital (US)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,907
Closed -$818K 333
2024
Q2
$818K Buy
19,907
+4,611
+30% +$190K 0.01% 207
2024
Q1
$714K Buy
+15,296
New +$714K 0.02% 142